KRT19 and endometrioid adenocarcinoma: Cytokeratin 19 (CK-19) was studied as a diagnostic marker of adenocarcinoma, which is known as a marker of endometrioid adenocarcinomas, pancreatic adenocarcinoma and head and neck cancer [19] (Figure 5d).